BioNexus Gene Lab Corp (NASDAQ: BGLC) Stock Information | RedChip

BioNexus Gene Lab Corp (NASDAQ: BGLC)


$0.52
-0.0104 ( -1.96% ) 40.0K

BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.

Market Data


Open


$0.52

Previous close


$0.53

Volume


40.0K

Market cap


$9.36M

Day range


$0.48 - $0.53

52 week range


$0.31 - $16.20

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 15 Apr 01, 2024
nt Quarterly Reports 1 Mar 28, 2024
10-q/a Quarterly Reports 65 Mar 26, 2024
def Proxies and info statements 1 Feb 29, 2024
pre Proxies and info statements 1 Jan 26, 2024
10-q Quarterly Reports 5 Nov 20, 2023
nt Quarterly Reports 1 Nov 14, 2023
8-k 8K-related 14 Nov 13, 2023
8-k 8K-related 14 Nov 03, 2023
8-k/a 8K-related 14 Oct 30, 2023

Latest News